Search

Author/Creator Wardecki, M.

1. Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12‐month trial including 6‐month extension. Issue 12 (14th September 2015)

Authors:
Yki‐Järvinen, H.; Bergenstal, R. M.; Bolli, G. B.; Ziemen, M.; Wardecki, M.; Muehlen‐Bartmer, I.; Maroccia, M.; Riddle, M. C.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 12(2015:Dec.)
Page Start:
1142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK WASHOUT PERIOD IN PHASE 3 CARDINAL STUDY (NCT03347396). (23rd June 2022)

Authors:
Röth, A.; Barcellini, W.; D'Sa, S.; Miyakawa, Y.; Broome, C. M.; Michel, M.; Kuter, D. J.; Jilma, B.; Tvedt, T. H. A.; Weitz, I. C.; Sourdille, T.; Wang, J.; Vagge, D. S.; Kralova, K.; Shafer, F.; Wardecki, M.; Lee, M.; Berentsen, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY. (23rd June 2022)

Authors:
Röth, A.; Barcellini, W.; D'Sa, S.; Miyakawa, Y.; Broome, C. M.; Michel, M.; Kuter, D. J.; Jilma, B.; Tvedt, T. H. A.; Weitz, I. C.; Sourdille, T.; Wang, J.; Vagge, D. S.; Kralova, K.; Shafer, F.; Wardecki, M.; Lee, M.; Berentsen, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search